BIOMERIEUX (BIM.PA) Stock Fundamental Analysis
EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR
BIM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. While BIM has a great health rating, its profitability is only average at the moment. BIM has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year BIM was profitable.
In the past year BIM had a positive cash flow from operations.
BIM had positive earnings in each of the past 5 years.
In the past 5 years BIM always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.49%, BIM is in the better half of the industry, outperforming 78.13% of the companies in the same industry.
BIM has a Return On Equity of 10.28%. This is in the better half of the industry: BIM outperforms 68.75% of its industry peers.
BIM's Return On Invested Capital of 9.33% is fine compared to the rest of the industry. BIM outperforms 76.56% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BIM is in line with the industry average of 8.47%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.49% | ||
| ROE | 10.28% | ||
| ROIC | 9.33% |
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
1.3 Margins
With a decent Profit Margin value of 10.86%, BIM is doing good in the industry, outperforming 70.31% of the companies in the same industry.
In the last couple of years the Profit Margin of BIM has remained more or less at the same level.
BIM's Operating Margin of 14.79% is fine compared to the rest of the industry. BIM outperforms 70.31% of its industry peers.
BIM's Operating Margin has improved in the last couple of years.
The Gross Margin of BIM (55.66%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.79% | ||
| PM (TTM) | 10.86% | ||
| GM | 55.66% |
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
2. Health
2.1 Basic Checks
BIM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BIM has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, BIM has less shares outstanding
Compared to 1 year ago, BIM has an improved debt to assets ratio.
2.2 Solvency
BIM has an Altman-Z score of 6.94. This indicates that BIM is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.94, BIM belongs to the best of the industry, outperforming 92.19% of the companies in the same industry.
BIM has a debt to FCF ratio of 1.53. This is a very positive value and a sign of high solvency as it would only need 1.53 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.53, BIM belongs to the top of the industry, outperforming 84.38% of the companies in the same industry.
A Debt/Equity ratio of 0.08 indicates that BIM is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.08, BIM belongs to the best of the industry, outperforming 84.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.53 | ||
| Altman-Z | 6.94 |
ROIC/WACC1.2
WACC7.79%
2.3 Liquidity
A Current Ratio of 2.20 indicates that BIM has no problem at all paying its short term obligations.
The Current ratio of BIM (2.20) is better than 67.19% of its industry peers.
BIM has a Quick Ratio of 1.29. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
BIM has a better Quick ratio (1.29) than 64.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
BIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.01%, which is quite impressive.
The Earnings Per Share has been growing by 10.91% on average over the past years. This is quite good.
The Revenue has grown by 8.31% in the past year. This is quite good.
The Revenue has been growing by 8.27% on average over the past years. This is quite good.
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%
3.2 Future
BIM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.83% yearly.
Based on estimates for the next years, BIM will show a small growth in Revenue. The Revenue will grow by 6.78% on average per year.
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y13.83%
Revenue Next Year7.29%
Revenue Next 2Y7.04%
Revenue Next 3Y7.59%
Revenue Next 5Y6.78%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
BIM is valuated quite expensively with a Price/Earnings ratio of 31.61.
Compared to the rest of the industry, the Price/Earnings ratio of BIM indicates a somewhat cheap valuation: BIM is cheaper than 62.50% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BIM to the average of the S&P500 Index (26.52), we can say BIM is valued inline with the index average.
The Price/Forward Earnings ratio is 26.31, which means the current valuation is very expensive for BIM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BIM is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.25, BIM is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.61 | ||
| Fwd PE | 26.31 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BIM is valued a bit cheaper than 65.63% of the companies in the same industry.
BIM's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BIM is cheaper than 60.94% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 44.91 | ||
| EV/EBITDA | 16.07 |
4.3 Compensation for Growth
BIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of BIM may justify a higher PE ratio.
BIM's earnings are expected to grow with 15.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.57
PEG (5Y)2.9
EPS Next 2Y16.12%
EPS Next 3Y15.21%
5. Dividend
5.1 Amount
With a yearly dividend of 0.75%, BIM is not a good candidate for dividend investing.
BIM's Dividend Yield is a higher than the industry average which is at 2.33.
With a Dividend Yield of 0.75, BIM pays less dividend than the S&P500 average, which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.75% |
5.2 History
On average, the dividend of BIM grows each year by 19.40%, which is quite nice.
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
5.3 Sustainability
23.18% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP23.18%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPA:BIM (6/6/2025, 7:00:00 PM)
122
+1.5 (+1.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners20.96%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap14.44B
Analysts75.29
Price Target127.5 (4.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.75% |
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP23.18%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.02%
PT rev (3m)1.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.77%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.61 | ||
| Fwd PE | 26.31 | ||
| P/S | 3.63 | ||
| P/FCF | 44.91 | ||
| P/OCF | 21.64 | ||
| P/B | 3.43 | ||
| P/tB | 4.84 | ||
| EV/EBITDA | 16.07 |
EPS(TTM)3.86
EY3.16%
EPS(NY)4.64
Fwd EY3.8%
FCF(TTM)2.72
FCFY2.23%
OCF(TTM)5.64
OCFY4.62%
SpS33.63
BVpS35.53
TBVpS25.2
PEG (NY)1.57
PEG (5Y)2.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.49% | ||
| ROE | 10.28% | ||
| ROCE | 12.7% | ||
| ROIC | 9.33% | ||
| ROICexc | 9.83% | ||
| ROICexgc | 13.6% | ||
| OM | 14.79% | ||
| PM (TTM) | 10.86% | ||
| GM | 55.66% | ||
| FCFM | 8.08% |
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexcg growth 3Y-22.62%
ROICexcg growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.53 | ||
| Debt/EBITDA | 0.39 | ||
| Cap/Depr | 106.34% | ||
| Cap/Sales | 8.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 73.01% | ||
| Profit Quality | 74.39% | ||
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 6.94 |
F-Score7
WACC7.79%
ROIC/WACC1.2
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y13.83%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%
Revenue Next Year7.29%
Revenue Next 2Y7.04%
Revenue Next 3Y7.59%
Revenue Next 5Y6.78%
EBIT growth 1Y34.12%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year61.98%
EBIT Next 3Y26.54%
EBIT Next 5Y19.55%
FCF growth 1Y200.19%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y49.82%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%